CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $27.94M, above the global median of $16.24M
- FinancialsAltman Z-Score 4.01: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.25%
Annual Rate
CNY 0.60Paid annual
Payback Period
44.6 yr
Last Ex-Dividend
Jun 5, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.71BCNY551.87M · vs all stocks (USD)
Trailing P/E
24.85xRevenue (TTM)
1.34BCNY199.51M · vs all stocks (USD)
Profit Margin
11.33%Beta
0.1100xvs all stocks
52-Week Change
-11.15%vs all stocks
Market Capitalization
3.71BCNY551.87M · vs all stocks (USD)
Enterprise Value
3.93BCNY584.27M · vs all stocks (USD)
Trailing P/E
24.85xPrice to Sales (TTM)
2.81xPrice to Book (MRQ)
2.05xEnterprise to Revenue
2.93xEnterprise to EBITDA
12.79xGross Margin
27.48%Profit Margin
11.33%Operating Margin
13.96%Return on Assets (TTM)
4.47%Return on Equity (TTM)
8.37%Revenue (TTM)
1.34BCNY199.51M · vs all stocks (USD)
Revenue per Share (TTM)
9.88CNYUpdated Aug 21, 2026Quarterly Revenue Growth
1.90%Gross Profit (TTM)
380.81MCNY56.63M · vs all stocks (USD)
EBITDA (TTM)
189.59MCNY28.19M · vs all stocks (USD)
Net Income (TTM)
152.02MCNY22.61M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.90%Operating Cash Flow (TTM)
233.23MCNY34.68M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
187.89MCNY27.94M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.6000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.25%vs all stocks
Minority Interest (Equity)
7.38MCNYFY2025 · Dec 31, 2025Revenue
1.34BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
955.04MCNYFY2025 · Dec 31, 2025Gross Profit
380.00MCNYFY2025 · Dec 31, 2025Operating Income
187.53MCNY27.89M · vs all stocks (USD)
Pre-tax Income
172.64MCNYFY2025 · Dec 31, 2025Income Tax Expense
23.66MCNYFY2025 · Dec 31, 2025Net Income
148.99MCNYFY2025 · Dec 31, 2025EBIT
183.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
319.01MCNYFY2025 · Dec 31, 2025Research & Development
81.53MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
39.58MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
504.61KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
10.68MCNYFY2025 · Dec 31, 2025EPS (Basic)
1.11CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.11CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
136.01MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
136.01MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
148.99MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.98MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-260.59MCNYFY2025 · Dec 31, 2025Free Cash Flow
-312.55MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
423.87MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
148.99MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.76MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-414.81MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.53MCNYFY2025 · Dec 31, 2025Capital Expenditures
-51.96MCNYFY2025 · Dec 31, 2025Purchase of Investments
-36.00MCNYFY2025 · Dec 31, 2025Sale of Investments
13.90MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-74.06MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
551.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-461.32MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-64.89MCNYFY2025 · Dec 31, 2025Other Financing Charges
-11.49MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
13.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
135.44MSharesUpdated Aug 21, 2026Float Shares
56.33MSharesUpdated Aug 21, 2026% Held by Insiders
61.78%vs all stocks
% Held by Institutions
5.31%vs all stocks
Total Cash (MRQ)
438.46MCNY65.20M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.24CNYUpdated Aug 21, 2026Total Debt (MRQ)
591.52MCNY87.96M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3213xCurrent Ratio (MRQ)
1.39xBook Value per Share (MRQ)
13.54CNYUpdated Aug 21, 2026Total Assets
2.59BCNY385.73M · vs all stocks (USD)
Total Current Assets
906.15MCNYFY2025 · Dec 31, 2025Total Liabilities
791.01MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.69BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
95.35MCNYFY2025 · Dec 31, 2025Total Current Liabilities
695.66MCNYFY2025 · Dec 31, 2025Cash
423.87MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
423.87MCNYFY2025 · Dec 31, 2025Accounts Receivable
200.27MCNYFY2025 · Dec 31, 2025Inventory
206.11MCNYFY2025 · Dec 31, 2025Accounts Payable
112.43MCNYFY2025 · Dec 31, 2025Short-term Debt
508.14MCNYFY2025 · Dec 31, 2025Other Current Liabilities
835.98KCNYFY2025 · Dec 31, 2025Long-term Debt
66.54MCNYFY2025 · Dec 31, 2025Common Stock (Book)
135.44MCNYFY2025 · Dec 31, 2025Retained Earnings
652.49MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY268.10M · vs all stocks (USD)
52-Week Low
21.90CNYUpdated Aug 21, 202652-Week High
30.80CNYUpdated Aug 21, 202652-Week Change
-11.15%vs all stocks
Beta
0.1100xvs all stocks
50-Day MA
25.08CNYUpdated Aug 21, 2026200-Day MA
26.39CNYUpdated Aug 21, 2026Avg 10-Day Volume
1.90MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.64MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
1.12CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.01: safe zoneNotable
Altman Z-Score: 4.01
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $27.94M, above the global median of $16.24MNotable
Levered free cash flow (USD): 27,940,527.06Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Kingchem Liaoning Life Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Relmada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Morepen Laboratories Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Altimmune, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
NeuroPace Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sailun Biotech Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Boryung Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pulike Biological Engineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangsu Hengli Hydraulic Co., Ltd.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
H. Lundbeck A/S
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Mastercard Incorporated
1 interpretationMulti-Year Revenue, Profit, And Income Growth